期刊
ANTIVIRAL RESEARCH
卷 85, 期 1, 页码 245-265出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.antiviral.2009.09.015
关键词
Human Immunodeficiency Virus; Antiretroviral resistance; Antiretroviral treatment; Genotype; Phenotype; Ultrasensitive resistance testing; Allele-specific PCR; Ultradeep sequencing
Antiretroviral drug resistance is a fundamental Survival strategy for the Virus that stems from its vast capacity to generate diversity. With the recent availability of new ARV drugs and classes, it is now possible to prescribe fully active ART to most HIV-infected subjects and achieve viral suppression even in those with multidrug-resistant HIV. It is uncertain, however, if this scenario will endure. Given that ART must be given for life, and new compounds other than second-generation integrase inhibitors may not reach the clinic soon, all efforts Must be done to avoid the development of resistance to the new agents. Here, we discuss relevant aspects for the clinical management of antiretroviral drug resistance, leaving detailed explanations of mechanisms and mutation patterns to other articles in this issue. This article forms part of a special issue of Antiviral Research marking the 25th anniversary of antiretroviral drug discovery and development, vol. 85, issue 1, 2010. (C) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据